Virbac: Rodolphe Durand appointed as non-voting advisor on the board of directors
2021/06/21 - Financial public releases
As a non-voting advisor, his role will be mainly to support the good governance of our company by strengthening the complementarity of the skills of the board of directors.
speed-connect.vet: making in-clinic diagnostic monitoring even easier
2021/06/15 - Products
Since 2017, we have been offering European veterinarians Speed ReaderTM, an in-clinic analyzer for the determination of blood markers and a series of biomarker tests. This year, we are enriching our in-clinic diagnostic solutions with a software that allows all analyses to be collected on a single digital platform, for optimal monitoring of each animal.
Virbac ready to sell the industrial site of Magny-en-Vexin (Paris) to the company Friulchem
2021/05/25 - Press
As part of its 2030 vision, Virbac sells the ownership and activity of the Magny-en-Vexin industrial site to Friulchem, a CMO (Contract manufacturing organization) partner of Virbac for more than twenty years and specialized among others in the production of antibiotics. Following the sharp decline in demand in recent years for the type of products manufactured in Magny-en-Vexin, this option will preserve employment, the competitiveness of the site and products.
Osteoarthritis in dogs: a new breakthrough in the treatment of pain
2021/05/12 - Press
Agreement signed for the distribution in Europe of a new weekly anti-inflammatory drug.
A new breath for the treatment of respiratory diseases in livestock
2021/04/22 - Products
Respiratory diseases are one of the most common pathologies affecting cattle and swine: all over the world, they are responsible for a high mortality rate in herds and significant economic losses. At Virbac, we support a reasonable use of antibiotics by using new technologies to help veterinarians and farmers make the right treatment decision at the right time and improve dosage and traceability.
2021 first quarter consolidated sales
2021/04/15 - Financial public releases
Aquaculture : Michael Fontaine appointed technical and development director
2021/04/15 - Career
Our new Group aquaculture technical and development director joins Virbac as of April 1, 2021 to accelerate our development in this promising sector.
2020 annual results
2021/03/17 - Financial public releases
Companion animals: Virbac takes over assets from Elanco
2021/03/01 - Press
Information following the approval of the European competition authorities
Algenex and Virbac sign international commercial licensing agreement for CrisBio®-based vaccine in major swine indication
2021/02/24 - Press
Find out the press release issued on February 23rd.
Virbac Opens Its First Research And Development Center Dedicated To Warm Water Aquaculture
2021/02/23 - Press
Today, we are inaugurating our first research and development center dedicated to warm water aquaculture in the Dong Nai province in Vietnam. Aquaculture is a rapidly growing sector, particularly in Asia, and provides an answer to the problems of feeding a world population that could reach 9 billion people in 2030. True to our mission to work for animal health, we continue to invest in order to offer new solutions for more sustainable aquaculture.
Gaia Index: Virbac progresses in the ranking!
2021/02/12 - Press
We are improving our presence in the ranking of the 70 French companies with the best ratings in terms of social and environmental responsibility.
2020 fourth quarter consolidated sales
2021/01/19 - Financial public releases
Virbac and Symbiocelltech sign exclusive option agreement to develop novel technology for treatment of type 1 diabetes in companion animals.
2021/01/13 - Press
Discover the press release issued on january 12th
Our new solution for the treatment of canine mast cell tumors available soon for american veterinarians
2020/12/21 - Products
On November 16, 2020 the Food and Drug Administration (FDA) granted approval of our new treatment against canine skin tumors. With this approval, we bring U.S. veterinarians a true innovation in canine oncology and a new option to manage mast cells tumors, the most common skin cancer diagnosed in dogs.
Happy season’s greetings!
2020/12/18 - Press
Discover the video of Sébastien Huron, chief executive officer of the Virbac group, for the end of the year 2020.
2020: discover 2020 overview!
2020/12/11 - Press
Ensuring the safety of our employees and maintaining our business essential to the animals' health. These are the two major challenges met in 2020 facing an unprecedented health crisis. We would like to share with you the panorama of this exceptional year on video.
Animal Needs Are Evolving, And So Are Our Health Solutions!
2020/11/26 - Products
The longer life span of pets goes hand in hand with the increase in geriatric diseases, particularly the number of cancers being diagnosed. Since the beginning of 2020, we have been offering European veterinarians an innovative treatment solution that specifically targets mastocytomas, the most common form of canine skin cancer.
2020 third quarter consolidated sales
2020/10/14 - Financial public releases
Revenue grew +6.8% at constant exchange rates and scope at the end of September 2020 (+5.6% at constant rates) thanks to solid third quarter performance
Virbac governance evolution
2020/10/13 - Financial public releases
Virbac partners with Ictyogroup to bring new aquaculture solutions
2020/09/17 - Press
Full details of this new partnership can be found in the joint press release issued on September 15.
2020 half year results
2020/09/16 - Financial public releases
2020 second quarter consolidated sales
2020/07/20 - Financial public releases
We can all enhance our pet’s dental hygiene
2020/07/15 - Products
By 2 years of age, 70% of cats and 80% of dogs have some form of dental disease (Niemiec BA., 2008). Dental care prevention is key to avoid serious and painful disorders that can affect pets’ overall health and lifespan. Let's discover together in this video how we can improve our four-legged companions’ dental hygiene!
Divestment of US rights
2020/07/02 - Financial public releases
Virbac completes divestment of U.S. Rights to SENTINEL® brands to MSD Animal Health
Foster a responsible use of parasiticides
2020/06/24 - Products
7.7 billion people on Earth, half live with pets. Every day, dogs and cats are exposed to unwanted parasites, vectors of various diseases that can affect their health and sometimes our own. We are all part of the same ecosystem. Protection against parasites is therefore a necessity that imposes to find the right balance between the health of animals, humans and their environment. That’s why our solutions allow veterinarians and owners to adapt protection to the specific parasite risk of each animal so that, all together, we can contribute to a responsible use of parasiticides.
Manage your dog's behaviour & fertility
2020/06/12 - Products
In a growing number of countries, companion animals are considered to be sentient beings that are a part of the family. Although sterilization is sometimes necessary, the methods to manage dogs’ fertility and unwanted behaviours are changing to take societal expectations into consideration.
Virbac Oncology Summit: veterinarians mobilize around the treatment of canine skin tumors
2020/05/13 - Press
On April 24, more than 350 veterinarians and experts attended our first scientific summit dedicated to veterinary oncology. Thanks to this exclusive online event, European and North American practitioners have been able to discover the latest scientific data and a new treatment option of canine mast cell tumors.
Signing of an agreement
2020/05/13 - Financial public releases
Carros: one of our worldwide production site of dog and cat vaccines will be stopped for at least 6 weeks
2020/05/04 - Press
Since April 11, 2020, following an underground pipeline rupture, our Bio4 dog and cat vaccine production site has been shut down. We expect to resume operations in June, after a refurbishment allowing the resumption of manufacturing under GMP (Good manufacturing practice) rules.
2020 first quarter consolidated sales
2020/04/15 - Financial public releases
Covid-19: Virbac teams mobilized
2020/03/27 - Press
Since the beginning of the coronavirus outbreak, numerous measures have been taken around the world to protect the health and safety of our employees and ensure the continuity of our commitment to animal health.
Imago: a promising first assessment
2020/03/19 - Press
Today, more than ever, we are striving to make our animal health solutions even more accessible to veterinarians, farmers and animal owners around the world. This is why in 2019, we launched a pilot program in France to transform our industrial activities. A great adventure for our teams, who are mobilising all their know-how to continue to develop the Virbac production sites in terms of performance, safety and quality. Watch the 2019 achievements in video.
2019 annual results
2020/03/16 - Financial public releases
Pebble Labs and Virbac announce the signing of a comprehensive commercial agreement for aquaculture disease prevention
2020/03/11 - Press
Find out the press release dated March 9.
CALF HEALTH IS THE FUTURE OF THE HERD
2020/02/26 - Products
Neonatal gastroenteritis is the leading cause of calf mortality before the age of one month and causes significant losses to farmers. With our Calf Care Solutions program, we work with veterinarians and farmers to adopt a comprehensive calf health management approach that integrates diagnosis, prevention and care. Our goal is to share our tools and technical knowledge to more effectively manage on-farm diarrhea episodes through sustainable farming practices that respect animal welfare.
Asia: better meeting tomorrow's food needs
2020/01/30 - Press
End of November, the Virbac teams shared for one day the groundbreaking ceremony of a new research & development center in Taiwan. This site will be dedicated to the support of aquaculture and swine farming activities in Asia.
Virbac opens a new path in the treatment of canine skin tumors
2020/01/20 - Products
Through its partnership with QBiotics, Virbac is providing veterinarians in Europe with a breakthrough injectable solution to treat mastocytoma in dogs. With this new treatment, the Group once again demonstrates its commitment and ability to offer innovative solutions for the advancement of veterinary science.
2019 Annual consolidated sales
2020/01/16 - Financial public releases
Happy new year!
2020/01/06 - Press
Sébastien Huron, chairman of the executive board of the Virbac group, wishes a happy new year for 2020 through a video.
The Group raises the 2019 annual outlook
2019/12/20 - Financial public releases
Mexico: Virbac supports young French companies
2019/12/05 - Press
As part of the French Fab mission lead by the French public investment bank (Bpifrance), Virbac sponsors a support mission in 2019 for young French companies wishing to establish themselves in Mexico.
An extra help for dogs’ relaxation and mobility
2019/11/26 - Products
Behavior disorders and joint problems are common in dogs and can affect their quality of life and their relationship with humans. With multifunctional chews, pet owners now have an easy to give solution to support their pet’s overall health and wellness, while acting on their dental hygiene.
Dog obesity: a complete program offered by Virbac
2019/11/15 - Products
Today 25 to 40% of dogs are overweight or obese. This is true everywhere in the world, whatever the size or breed. Since obesity can have serious health consequences, Virbac offers, in partnership with an expert in dog activity, PitPat, a comprehensive program combining a healthy diet and the measurement of the dog's activity using a device placed on its collar. Find out more about this approach that helps improve the relationship between the owner and his pet by watching the video below.
Jean-Pierre Dick steps down from the executive board of the Virbac group
2019/11/05 - Press
Virbac has accepted Jean-Pierre Dick’s resignation from the executive board, effective November 14, 2019.
Micro-nutrition: a key role in feeding ruminants
2019/10/15 - Products
Today, farmers have to ensure optimal farming conditions both for the animal welfare and productivity. Yet, in the lifetime of an animal or during the production cycle, there are periods where induced oxidative stress is particularly intense. In such cases, farmers have to supplement animals with trace mineral elements. To learn more about micro-nutrition, click below to watch the video.
2019 third quarter consolidated sales
2019/10/11 - Financial public releases
Virbac Mexico celebrates 30 years
2019/10/11 - Press
This year marks the 30th year of Virbac’s iconic Latin American subsidiary, and they wished to celebrate the past thirty years of innovation and dedication to animal health along with their employees and customers on October 5, 2019. With a unique vision aligned to the Virbac Group’s values, the company has always taken its environmental impact and its social responsibility towards employees to heart.
Stock exchange: Virbac again in the SBF 120
2019/09/19 - Financial public releases
Following the quarterly review of its indices, the Paris stock exchange operator, Euronext, includes Virbac in the CAC Mid 60 and SBF 120 as from 23 September.
2019 half year results
2019/09/16 - Financial public releases
China: a new technology to support dental hygiene in dogs
2019/09/05 - Products
A major concern for pet owners, bad breath can disrupt the close bond between pet and owner and signal deeper health issues. In 2019, for the first time ever in China, Virbac introduced dental care solutions that include FR3SH™ technology to target the oral and digestive causes of bad breath.
Newcomers digital programme: a better way of sharing the corporate culture
2019/08/02 - Career
In early June, Virbac launched a digital program dedicated to all new employees. Objective: within the first weeks of their arrival, build a common foundation of knowledge about the Group, its operations and its corporate culture.
Cyrille Petit appointed as a member of the Virbac supervisory board
2019/07/18 - Financial public releases
Virbac announces the arrival of Cyrille Petit as a member of the supervisory board as of June 18, 2019. In addition, on the audit committee he will replace Olivier Bohuon, who is also a member of the supervisory board.
2019 second quarter consolidated sales
2019/07/16 - Financial public releases
Turkey: the first veterinary vaccine against canine leishmaniosis
2019/07/10 - Products
In Turkey, the prevalence of canine leishmaniosis can reach 25% in some regions, especially around the Mediterranean basin. To face this zoonosis that is currently under-diagnosed by veterinarians and misunderstood among Turkish owners, Virbac has made available, since March 2019, CANILEISH®, the first veterinary vaccine to prevent this disease.
Sustainable development: an ever-greater commitment
2019/06/06 - Press
As part of its 2018 annual report, Virbac published its first non-financial performance statement in April. This document marks a new stage for the Group, who is reinforcing its commitments to sustainable development.
Vietnam: a sustainable collaboration with farmers
2019/05/21 - Press
End of 2018, the Virbac Husbandry Club in Vietnam, which helps pig and poultry farmers tackle local animal health issues, celebrated 10 years of activity. This 10th anniversary is a testament to the Group’s drive to carry out sustainable actions that promote improvement in farming conditions.
Disability: fostering job retention
2019/04/18 - Career
As part of its diversity policy, Virbac has been conducting concrete actions for the recruitment, better integration and job retention of workers with disabilities since 2014 in France.
2019 first quarter consolidated sales
2019/04/11 - Financial public releases
United Kingdom: the Veterinary HPM™ campaign wins an award!
2019/04/05 - Products
Mid-March, Virbac was rewarded in the United Kingdom for its digital Veterinary HPM™ campaign by the VMA (Veterinary marketing association), which annually celebrates the best marketing initiatives in the field of animal health.
Innovation: the Smart Cap “all in one” is rewarded again!
2019/03/20 - Press
Each year, the ADF Paris awards honor the packaging innovations of the global aerosol and dispensing industries. Last January, the Virbac Smart Cap "all-in-one", already awarded in 2018 by Pharmapack, received the prize for the best innovation in the "Pharmacy" category.
2018 annual results
2019/03/18 - Financial public releases
Dogs’ dental health: an online awareness campaign that really bites!
2019/01/31 - Products
At the end of 2018, Virbac launched an online campaign in North America encouraging owners to consult their veterinarian about their dog’s dental health. It included a humorous video broadcasted on social networks, featuring a rubber toy that hates being chewed by a dog with bad breath.
2018 Annual consolidated sales
2019/01/17 - Financial public releases
François Fournier named president and CEO of Virbac North America
2019/01/16 - Career
Virbac announces François Fournier’s appointment as president and CEO of Virbac North America, effective January 7, 2019. His main mission is to lead and develop all North American Virbac activities, in line with the Virbac Group’s global strategy.
Happy new year!
2019/01/10 - Press
Sébastien Huron, chairman of the executive board of the Virbac group, wishes all the best for 2019 through a video.
Virbac websites: make the access to information easier
2018/12/21 - Press
In 2018, several Virbac websites were revamped: new contents, new design, new functionalities… all these changes aim at creating a better user experience.
United States: in-house manufacturing of Virbac flagship parasiticide
2018/12/06 - Products
In August, the FDA approved the transfer of production to the Virbac St. Louis site (Missouri) of a parasiticide for dogs acquired by the company at the beginning of 2015. The complexity of the industrial extrusion process required all the skills and attention of the American subsidiary and the Group's Production/Quality teams for nearly three years.
A better dental care for an optimal dogs’ health
2018/11/22 - Products
Bad breath is a common complaint of dogs’ owners but it can also be a sign of periodontal or digestive issues that can be painful for the pet. Thanks to a new formula, the C.E.T® VEGGIEDENT® FR3SH™ dental chews tackle the oral causes of bad breath and help to restore the animal's intestinal balance while freshening its breath. Available since 2018 in the United States, Canada, the United Kingdom, France, Spain and Japan, they will gradually be present around the world in 2019.
Gaïa Index: Virbac ranked again in 2018!
2018/11/13 - Press
In 2018, Virbac is part of the Gaïa Index, which recommends the 70 French companies with the best ratings in terms of social and environmental responsibility among a panel of 230 firms. Virbac has made a significant improvement of 14 places in the overall ranking compared to 2017.
Turkey: Virbac closer to the field
2018/10/23 - Press
After a twenty-year presence in Turkey through a local distributor, Virbac is creating its 33rd subsidiary there. The objective: closer proximity in order to better respond to the expectations of animal health players.
2018 third quarter consolidated sales
2018/10/11 - Financial public releases
2018 half year results
2018/09/17 - Financial public releases
2018 second quarter consolidated sales
2018/07/17 - Financial public releases
Virbac wins the Pharmapack Award with its “all-in-one” Smart Cap
2018/06/12 - Press
After five years of research and development, Virbac teams have developed Smart Cap, dedicated to extracting liquid products. This patented innovation benefitting animal health, which combines ergonomics and safety, was recognized in early 2018 with a Pharmapack Award.
Virbac United States announces Eric Bonner as vice president of Industrial Operations
2018/04/17 - Career
Virbac United States announced that Eric Bonner has been named vice president of Industrial Operations.
Supporting farmers to better manage swine reproduction
2018/04/12 - Products
One of the present challenges of swine producers is finding solutions that preserve farm productivity while reducing the use of antibiotics. In Europe, Latin America and Asia, Virbac is assisting veterinarians and farmers with technical solutions and on farm training that focus on prevention and are based on a good reproduction management.
2018 first quarter consolidated sales
2018/04/12 - Financial public releases
Webcast 2017 annual results
2018/03/19 - Financial public releases
2017 annual results
2018/03/14 - Financial public releases
Facilitate diagnosis to better care for the animal
2018/02/28 - Products
Since 2017, Virbac has been offering veterinarians Speed ReaderTM, a blood marker dosage analyzer with a series of biomarker tests. Usable directly in-clinic, these newest additions to the diagnostic range facilitate screening of common diseases in cats and dogs and ensure better monitoring of the animal.
Healthy cows make better milk!
2018/01/17 - Products
Maintaining good health and welfare of cows is central to Virbac's approach of dairy production. Virbac created a specific program for professionals of dairy farming called Target 150. This program aims at bringing global & integrated solutions and protocols for a better and more sustainable production of milk. Developed in close cooperation with worldwide known experts, Target 150 ™ encourages prevention and answers the main problematics of the 150 critical days of production cycle of the dairy cows. As an essential part of the program, the second Virbac Dairy Symposium was organized in September 2017 to contribute strengthening the skills of dairy farming professionals and prepare them to the emerging technologies of tomorrow.
2017 Annual consolidated sales
2018/01/16 - Financial public releases
Happy new year!
2018/01/08 - Press
For 2018, find out the video wishes from Sébastien Huron, new chairman of the executive board of the Virbac group.
Sébastien Huron officially takes office as chairman of the Virbac group executive board
2017/12/21 - Career
Yesterday, Virbac’s supervisory board officially appointed Sébastien Huron as chairman of the Group’s executive board. Sébastien Huron succeeds Éric Marée, chairman of the executive board for the past 18 years, who has retired.
China: Virbac acclaimed by the largest pet owners community
2017/12/05 - Press
In August 2017, Virbac was awarded pet owner favorite brand for cat health care by Goumin.com, the largest online Chinese pet owner community.
Aquaculture: Virbac postpones its option to buy Centrovet for three years
2017/11/22 - Financial public releases
ADULT WITH SALMON NEUTERED & ENTIRE CAT received a rating of 17.5/20 from INC - 60 Millions de Consommateurs french magazine June 2017 issue
2017/11/21 - Products
Two years after its launch, with a rating of 17.5/20, the VETERINARY HPM® Adult with salmon neutered & entire cat is one of the ‘best choices’ amongst thirteen dry cat foods (kibbles) tested by the INC (Institut National de la Consommation [French National Institute for Consumer Affairs]). This rating makes up for several years of development.
New solutions to fight against leishmaniosis in Brazil
2017/11/17 - Products
The treatment of dogs infected with leishmaniosis has been authorized in Brazil since 2016. Thanks to its publicity campaigns and its treatment solution introduced in January 2017, Virbac is contributing to the fight against this disease which, on a world scale, touches about 1 million of humans.
2017 third quarter consolidated sales
2017/10/12 - Financial public releases
VETERINARY HPM™ dietetic: a new generation of nutrition for cats and dogs
2017/10/06 - Products
VETERINARY HPM™ dietetic is a new generation of nutrition for cats and dogs with health problems, created by staying close to the nutritional requirements of carnivores, respecting the nutritional requirements of carnivores. These foods should be recommended by the veterinarian depending on the animal's health problem. A veterinarian's option should be sought before use. Available since spring 2017 in European veterinary clinics, the VETERINARY HPM™ dietetic range will also be launched in Latin America (Mexico, Costa Rica and Chile) by the end of the year.
Virbac group: Solène Madelpuech joins the supervisory board
2017/09/22 - Financial public releases
On September 5, 2017, Virbac’s supervisory board co-opted Solène Madelpuech into the supervisory board as a new member. On the same day, Jeanine Dick, aged 81, announced her resignation.
Virbac appoints Sophie Favini as executive vice-president of US commercial operations
2017/09/14 - Career
Virbac announces the appointment of Sophie Favini as executive vice-president of US commercial operations. Based in Fort-Worth (Texas), she is effective in her role since July 13, 2017. Sophie Favini is now in charge of leading, developing and overseeing all US Sales, Marketing and Technical Services functions in order to increase the business activity of the subsidiary.
Virbac also announces the appointment of Colin Meyers as vice-president of sales. These two appointments will help Virbac achieve a sustainable growth in the US.
2017 half year results
2017/09/11 - Financial public releases
Calf Health: Virbac boosts its expertise
2017/08/10 - Products
Whether in the meat or dairy industries, quality production requires animals that are healthy from birth onward! With this in mind, Virbac has been progressively rolling out a complete Calf health management program in Europe since 2016.
2017 second quarter consolidated sales
2017/07/17 - Financial public releases
Virbac group: Sébastien Huron will become the new chairman of the executive board as of December 2017
2017/06/23 - Career
Virbac has announced the supervisory board’s intention to appoint Sébastien Huron as chairman of Virbac’s executive board, as of next December, when the mandate of the current chairman of the executive board, Éric Marée, expires.
Virbac signs a research agreement with Bio-Gene
2017/06/16 - Press
Bio-Gene announces collaboration agreement with Virbac for development of FLAVOCIDE™ as an insect control agent in ruminants.
Effipro® Duo: treat and prevent flea and tick infestations
2017/05/31 - Products
In May 2016, European practitioners (France, UK and Austria) discovered Effipro® Duo, a new parasiticide used to treat and prevent tick and flea infestations in dogs and cats. The advantages of this product described by the Global Marketing manager parasiticides.
Virbac appoints Frédéric Jodogne as Corporate Industrial Operations director
2017/05/19 - Career
Virbac announces the appointment of Frédéric Jodogne as Corporate Industrial Operations director. Based in Carros, he is effective in his role since April 3, 2017. He is in charge of implementing, organizing and leading supply chain and industrial strategies of the Group.
Launch of the VETERINARY HPM™ Dietetic range in Europe!
2017/05/10 - Products
Following the launch of the VETERINARY HPM™ physiological range in 2015, Virbac started from March 1st the launch of VETERINARY HPM™ dietetic for dogs and cats in Europe. A complete range still close to the nutritional requirements of carnivores and associated to the "Veterinary global care", a new global nutritional approach.
Virbac United States selects KC Animal Health Corridor for North American distribution center
2017/05/04 - Press
The Virbac American subsidiary decided to gather its distribution operations in Hunt Midwest SubTropolis (Missouri). The new center should be operational until the end of the year.
2017 first quarter consolidated sales
2017/04/12 - Financial public releases
VETERINARY HPM® Adult Small & Toy: a rating of 16.4/20
2017/04/04 - Products
The product VETERINARY HPM® Adult Small & Toy has received a rating of 16.4/20 from the independent French consumer association UFC-Que Choisir. The cited product has been qualified as one of the “best choices” amongst the twenty complete dog foods that were tested.
Supporting innovation through public research
2017/03/31 - Press
Public-private transfer (TPP). Behind this acronym lies the possibility for French companies to develop partnerships with French and European public research organizations. This opportunity for innovation was seized on by Virbac in 2009 and presented by the public research partnerships manager.
2016 annual results
2017/03/13 - Financial public releases
e-visit: always closer to veterinarians
2017/02/27 - Press
In September 2016, on the initiative of the IT department, e-visits first appeared amongst the sales force in France. The purpose: allow greater reactivity from regional technical managers to questions from veterinarians. Explanations on this European-scale project by the market manager for Virbac France.
2016 Annual consolidated sales
2017/01/17 - Financial public releases
Jesse Mark Chellan appointed general manager of Virbac RSA
2017/01/04 - Career
Virbac announces the appointment of Jesse Mark Chellan as general manager of Virbac RSA. Based in Johannesburg, he is effective in his role since December 1, 2016. He will be responsible for the development and execution of the long term business strategy for both South Africa and for the export regions of Southern and Sub-Saharan Africa.
St. Louis: lifting of the Warning Letter for the Virbac production site
2016/12/16 - Financial public releases
2016 third quarter consolidated sales
2016/10/13 - Financial public releases
"Factories and Men" Exhibition: Virbac at the forefront!
2016/10/08 - Press
14 September 2015, Paris. The "Factories and Men" operation is being organised by 'Mouvement des entreprises de taille intermédiaire' (METI), an organisation which represents intermediate-sized businesses in France. The project began with a preview at the Petit Palais, and METI has organised a series of events which will take place until the end of 2015 with the aim of spotlighting the best of French industry. Thirty five businesses, including Virbac, are taking part.
Virbac China, still one step ahead
2016/09/29 - Products
Since 2012, Virbac has maintained a presence in China through a commercial subsidiary that now has about thirty collaborators. How is the subsidiary adapting to this ever-changing market? Answers by the subsidiary general manager.
2016 half year results
2016/09/19 - Financial public releases
USA: Virbac launches of unique canine joint health supplement
2016/09/19 - Products
On March 8, 2016, Virbac US announced the launch of the latest advancement in canine joint health supplementation, MOVOFLEX™ Soft Chews. Formulated with a unique and proprietary blend of ingredients, MOVOFLEX™ Soft Chews provide comprehensive canine joint support in a once-a-day palatable soft chew.
Marie-Paule Porte appointed Group general counsel at Virbac
2016/08/30 - Career
Virbac announces the appointment of Marie-Paule Porte as Group general counsel. Member of the strategic committee and the Comex France, in charge of legal matters at a global level, she provides support to the executive board and area directors in relation to strategic decisions they take.
Sustainable development: a new step
2016/07/28 - Press
In its 2015 report, Virbac adopted the most recent version of the GRI standard for sustainable development. The reasons behind this change and the related benefits explained by Éric Marée, chairman of the executive board.
2016 second quarter consolidated sales
2016/07/18 - Financial public releases
Habib Ramdani appointed chief financial officer at Virbac and member of the executive board
2016/06/29 - Career
Virbac announces the appointment of Habib Ramdani as chief financial officer. Appointed to the executive board on June 23, 2016, Habib has overseen all financial activities of the Group since taking office on May 2, 2016, reporting directly to Éric Marée, chairman of the Virbac group executive board.
Ary Rodrigues appointed general manager for Virbac in Brazil
2016/06/14 - Career
Virbac announces the appointment of Ary Rodrigues as general manager of Virbac do Brazil. Since January 2016, Ary’s main missions are to develop and implement long term commercial strategies, increasing market share and search of new business opportunities and services that can generate sustainable growth for Virbac in Brazil.
Andres Engelbreit appointed Latin American area director for Virbac
2016/05/09 - Career
Virbac announces the appointment of Andres Engelbreit as Latin American area director as of January 1, 2016. In conjunction with the business development, innovation and global marketing teams, Andres Engelbreit’s missions are to increase the Virbac’s market share in Latin America and improve its profitability in the area in a lasting way. He has been a development director in the area since 2012.
USA: Virbac launches a new dental Diagnostic Test
2016/05/02 - Products
On March 1, 2016, Virbac US announced the launch of the C.E.T.® OraStrip® Dental Diagnostic Test (currently distributed in the USA), the first and only test in the animal health market that detects periodontal infection in dogs, providing visual test results to support veterinarians’ dental treatment recommendations and enhance client compliance.
ACTIVYL® AND ACTIVYL® TICK PLUS
2016/04/22 - Products
Virbac has been distributing the parasiticide medicines Activyl® and Activyl® Tick Plus in Europe since January 1, 2016. The integration of these two medicines in the parasiticide product portfolio fulfils Virbac’s wish to offer complementary solutions to veterinarians.
2016 first quarter consolidated sales
2016/04/13 - Financial public releases
USA: Virbac creates 144 jobs in Bridgeton, Missouri
2016/04/13 - Press
Virbac is investing $37.9 millions in its production site in Bridgeton, Missouri.
Instrucciones: a new high quality facility
2016/03/17 - Press
A 3,600 m² space dedicated to production! At the end of September the new Instrucciones site was opened in Uruguay, with a special emphasis on quality. An introduction to this leading edge facility by the subsidiary’s general manager.
2015 annual results
2016/03/14 - Financial public releases
New tagline: Virbac shows its ambition!
2016/03/12 - Press
“Shaping the future of animal health”. This is now Virbac's new tagline, replacing “Passionate about animal health”, launched in 2001.
What message does this new slogan convey? Answers from Sandrine Brunel, head of Corporate Communications.
VETERINARY HPM: Virbac’s new generation Pet food!
2016/03/01 - Products
Virbac commercializes a new hyper premium nutritional concept for dogs and cats!
Over the last months, Virbac has progressively launched its new range Veterinary HPM™ for cats and dogs in more than ten European countries (Denmark, Switzerland, France, Portugal, Spain…).
VDS: Virbac's commitment to the dairy sector
2016/02/20 - Press
At the beginning of October the GMBO (Global Marketing) organized the first Virbac Dairy Symposium in France, attended by experts from the dairy sector and Virbac staff from all over the world. Fabrice Payot, Global Marketing manager on the dairy cattle segment, explains the objectives of this major event.
Colombia: vaccines for companion animals, a dominant position
2016/02/03 - Products
26%. This is 2014 Virbac Colombia's market share on the dog and cat vaccines segment. This figure is evidence of the success that the subsidiary has met with in this fast-growing sector. The story of a lightningfast journey by colombian Marketing manager.
Changing views on disability
2016/01/20 - Career
As well as gender equality, age equality, now it's the turn of disability.
As part of its diversity policy in France, at the end of 2014 Virbac signed an agreement with its social partners on this important theme within the company. Details of the content of this agreement with the diversity manager for France.
2015 Annual consolidated sales
2016/01/14 - Financial public releases
Jules Minke joins Virbac as biological R&D director for the Group
2015/11/06 - Career
Virbac announces the appointment of Jules Minke as Group biological Research and Development director. Jules Minke’s main task going forward is to coordinate and supervise all R&D activities and global teams involved in Virbac’s biological projects. He will also monitor regulatory activities in this area.
2015 third quarter consolidated sales
2015/10/15 - Financial public releases
2015 half year results
2015/09/15 - Financial public releases
Virbac appoints Steven Buchholz vice president, Quality & Compliance in the USA
2015/09/08 - Career
Virbac announced that Dr. Steven Buchholz has been appointed to the position of vice president, Quality & Compliance of Virbac U.S.
Virbac appoints Francesca Cortella as head of group Human Resources department
2015/08/03 - Career
Virbac has announced the appointment of Francesca Cortella as head of its group Human Resources department. Francesca Cortella will join the Strategic Committee and Executive Committee for France.
2015 second quarter consolidated sales
2015/07/16 - Financial public releases
Augmented reality: Virbac, the UK pioneer!
2015/07/03 - Products
November 2014, London. For its use of augmented reality technology Virbac UK is awarded the Best Large Stand award for the most innovative stand. Just a gadget or a genuine opportunity for improved communication? Some answers from the companion animal business unit director of the subsidiary.
Group's perspectives for 2015 impacted by the industrial situation in the United-States
2015/06/23 - Financial public releases
2015 first quarter consolidated sales
2015/06/15 - Financial public releases
Newcomers international: the platform for Virbac culture
2015/05/26 - Career
170. This is the number of newcomers joining Virbac subsidiaries who, since 2009, have taken part in the induction programme organized at headquarters by the Corporate Communications, in addition to local sessions. What are the benefits of this programme? Answers from the internal communications manager.
PEA-PME eligibility of Virbac
2015/03/24 - Financial public releases
2014 annual results
2015/03/16 - Financial public releases
2014 Annual consolidated sales
2015/01/15 - Financial public releases
St. Louis: to better serve product innovation
2015/01/09 - Press
Virbac United States inaugurates the April 20th, 2014 a new building for its R&D activities. With which objectives? The answers from R&D vice-president of the American subsidiary.
Virbac announces the closing of the SENTINEL® brands family acquisition in the United States
2015/01/05 - Financial public releases
Companion animals in Russia: a new start
2014/12/01 - Products
April 2014, Moscow. At Russia's largest veterinary congress, Virbac launched Cortavance, a corticoid for the treatment of inflammatory dermatosis in dogs. A major step forward for the companion animal portfolio in this country. Explanations by the Rest of Europe product manager.
Virbac Mexico: Virbac increases its global production capacity with its new site
2014/11/18 - Career
Following the opening of the new Virbac 8 site for production of sterile injectable forms at Carros near Nice, Virbac is unveiling the production site at Guadalajara (Mexico), which also specialises in sterile injectable forms.
Take your talent into new territories
2014/11/17 - Career
Formalize an employer message to support the company's international growth. This is the objective of Virbac. Details from the Head of Corporate Human Resources.
Browse Plus: a promising acquisition
2014/11/01 - Products
After Multimin in 2011, Virbac RSA finalized in 2012 the acquisition of the worldwide rights to Browse Plus, a nutritional supplement for food producing animals and leader on the South African market since 1994. This acquisition by Dayle Sinclair, product manager.
Virbac agrees to acquire veterinary assets from Eli Lilly in the United States
2014/10/27 - Financial public releases
2014 third quarter consolidated sales
2014/10/16 - Financial public releases
2014 half year results
2014/08/29 - Financial public releases
Anti-parasite treatment for cattle: Virbac awarded three prizes for its innovative Flexibag® and FarmPack® products
2014/08/01 - Products
In 2014, the innovative Flexibag® and Farmpack® products from Virbac were awarded three prizes: the 'Janus de la Santé' award for an environmentally-friendly design, the Pharmapack award and a "Sommet d’Or" award. In Flexibag® and Farmpack®, Virbac offer the first truly successful ergonomic design for simplified anti-parasite treatment of cattle and sheep, one which also improves productivity in the stock-rearing sector.
Chronic kidney disease: Pronefra is different
2014/07/31 - Products
France, Germany, Switzerland, Portugal, Austria, United Kingdom and Scandinavia. These were the first European countries to launch Pronefra in the first half of 2014. A presentation of this food supplement by the global marketing manager supportive care & topical hygiene.
2014 second quarter consolidated sales
2014/07/17 - Financial public releases
PEA-PME eligibility of Virbac
2014/04/23 - Financial public releases
2014 first quarter consolidated sales
2014/04/15 - Financial public releases
Australia: developing the ruminants vaccines of the future
2014/03/24 - Products
Viva VIVID! summer 2013, Virbac Australia opened a new R&D centre in Penrith surrounded by those involved in the local animal health industry. A key event for the development of the subsidiary’s biological activity in food producing animals. Explanations by Robert Dempster, the local RDL manager.
2013 annual results
2014/03/19 - Financial public releases
Virbac & V.I.E.: a win-win contract
2014/02/03 - Career
In five years, the number of V.I.E. (Volunteer for international experience) contracts at Virbac has more than doubled. How is this trend explained? Explanations of the HR generalist in charge of recruiting the V.I.E. for the Company.
2013 Annual consolidated sales
2014/01/16 - Financial public releases
Dental: digital serving Europe marketing
2014/01/14 - Products
May 2013, Prague. In partnership with the European Veterinary Dental Society, Virbac is launching the e.VDS, an application for evaluating animal dentition (scoring) and developing knowledge for veterinarians all over the world. A look at the tool’s functionalities and objectives with Alain Mondon, Global Marketing manager, companion animals parasiticides.
2013 third quarter consolidated sales
2013/10/17 - Financial public releases
2013 half year results
2013/08/30 - Financial public releases
2013 second quarter consolidated sales
2013/07/18 - Financial public releases
Diversity: a well established policy
2013/06/01 - Career
Interview with the Human Resources and diversity manager.
Neonatal calf diarrhoea in Europe: reference rapid in-practice diagnostic test improved
2013/05/03 - Products
The successful management of an outbreak of neonatal calf diarrhoea relies on the individual treatment of sick animals and the prevention of disease transmission. In this context, identification of the pathogens involved enables the vet to select the most appropriate treatment and prophylactic measures for each case.
2013 first quarter consolidated sales
2013/04/16 - Financial public releases
2012 annual results
2013/03/11 - Financial public releases
Electronic identification: 1st mini polymeric transponder in Europe
2013/02/10 - Products
Faithful to its strategy of continuous innovation, this year Virbac is launching the 1st mini polymeric transponder in Europe (France, Netherlands, Germany, Austria, Belgium), the BackHome® Biotec Slim Transponder.
2012 annual consolidated sales
2013/01/17 - Financial public releases
Virbac becomes a leader of the Aquaculture Health Market
2012/11/23 - Financial public releases
Gender equal opportunity: an agreement signed
2012/11/01 - Career
Virbac signs an agreement in France for gender equal opportunity in June 2012. An initial action which resulted in the diversity policy launched in 2011. Details of this agreement with the corporate reward manager.
2012 third quarter consolidated sales
2012/10/18 - Financial public releases
United States: two promising products
2012/10/15 - Products
Rilexine and Suprelorin F: two products launched in the American market mid 2012 thanks to the hard work of the Virbac US R&D teams to adapt the registration dossiers. A look at the challenges with Craig Parks, R&D vice-president.
VSA: improving the effectiveness of the sales force
2012/10/10 - Career
Virbac signs an agreement in France for gender equal opportunity in June 2012. An initial action which resulted in the diversity policy launched in 2011. Details of this agreement with the corporate reward manager.
Recruitment: enhancing support for managers
2012/10/01 - Career
Last September, twenty managers took part in a “successful recruitment” training session at headquarters organised by the Human Resources department. Objective? Share the different stages of the recruitment process. Explanations from the Talent manager.
2012 half year results
2012/08/31 - Financial public releases
2012 second quarter consolidated sales
2012/07/19 - Financial public releases
2012/06/25 - Financial public releases
Canine osteoarthritis: Virbac expands its product range in France
2012/06/01 - Products
Since June 2012, Virbac France has offered a long-term treatment that aims to reduce inflammation and pain for dogs with acute and chronic musculoskeletal disorders. This medicine adds to Virbac's canine osteoarthritis range which now provides comprehensive care for canine osteoarthritis.
2012 first quarter consolidated sales
2012/04/18 - Financial public releases
Pharmapack congress: a Virbac packaging rewarded
2011/04/01 - Products
01/02/2010. Paris - France. Pharmapack award "Home risks prevention - veterinary category" has been awarded to Milteforan, the first veterinary medicinal product intended to treat the leishmaniasis and that can be administered by oral route.
Companion animals: Virbac is releasing a new external parasiticide onto the European market
2009/05/25 - Products
The fruit of several years of development, Effipro® Spot On and Effipro® Spray are two Fipronil-based medicines which treat flea and tick infestations in dogs and cats.